Nebraska to Get Nearly $5M in Depakote Settlements

By: Associated Press
By: Associated Press

Nebraska will receive nearly $5 million from Abbott Laboratories to settle concerns that it improperly marketed its anti-seizure drug Depakote.

Nebraska Attorney General Jon Bruning says the state will receive a share of the $1.5 billion settlement Abbott agreed to.

Nebraska's Medicaid program will receive $3.7 million, and $1.2 million will go to the state's consumer settlement fund.

Depakote is an anti-seizure and mood-stabilizing drug that's prescribed for bipolar disorder. Abbott admitted marketing Depakote for unapproved uses including dementia and schizophrenia in violation of FDA rules.

The national settlement was announced Monday.

KOLN-TV Call: (402) 467-4321 Toll-free: 1-800-475-1011 840 North 40th Lincoln, NE 68503 Email: KGIN-TV Call: (308) 382-6100 123 N Locust Street Grand Island, NE 68802 Email: KSNB-TV Toll free 888-475-1011 123 N. Locust St. Grand Island, NE 68802 Email :
Copyright © 2002-2015 - Designed by Gray Digital Media - Powered by Clickability 150597265 -
Gray Television, Inc.